Neurology Today in 5
Avsnitt

New approved drug for neurofibromatosis 1 with plexiform neurofibromas, multidisciplinary clinics in neurology, impact of cuts to DEI research grants

Dela

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the newly approved drug for neurofibromatosis 1 with plexiform neuromas in adults, how neurology practices are integrating with multiple subspecialties, and the impact of federal cuts to DEI grants and research.

Podden och tillhörande omslagsbild på den här sidan tillhör American Academy of Neurology. Innehållet i podden är skapat av American Academy of Neurology och inte av, eller tillsammans med, Poddtoppen.

Senast besökta

Neurology Today in 5

New approved drug for neurofibromatosis 1 with plexiform neurofibromas, multidisciplinary clinics in neurology, impact of cuts to DEI research grants

00:00